covid vaccine
- India
Vaccines or villains? Govt admits multiple side-effects of Covid-19 jabs in RTI reply
Mumbai: It’s official. The government’s two top watchdogs have admitted to ‘multiple side-effects’ of Covid-19 vaccines that were jabbed in over a billion Indians in the past more than two years. The…
- Hyderabad
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
Hyderabad: Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. According…
- Hyderabad
Bharat Biotech’s intranasal COVID-19 vaccine priced at Rs 800
Hyderabad: Vaccine maker Bharat Biotech’s intranasal vaccine for COVID-19, the first in the world, is scheduled to be introduced in the country as a booster dose shortly. The vaccine, iNCOVACC (BBV154), is…
- India
Notices issued to Centre, Bill Gates, SII over plea on alleged COVID vaccine death
Mumbai: The Bombay High Court issued notices to the Government of India, Serum Institute of India (SII), Microsoft founder Bill Gates, All India Institute of Medical Science Director, DCGI chief and others…
- India
COVID vaccine: Precaution dose to be available for all adults from April 10
New Delhi: The precaution dose will now be available to the 18 plus population group from April 10 at private COVID-19 vaccination centres, said the Union Health Ministry on Friday. All those…
- India
Over 70% eligible teens get 1st dose of Covid vaccine
New Delhi: Over 70 per cent of the adolescents between the 15 to 18 age bracket have received their first dose of Covid vaccine. As per the government’s CoWIN portal, a total…
- Top Stories
90 pc of India’s adult population has received first dose of Covid vaccine: Prez
New Delhi: About 90 per cent of India’s adult population has received the first dose of COVID-19 vaccine whereas over 70 per cent have been administered both the doses, President Ram Nath Kovind…
- India
Covid vaccines administered in India cross 165 crore mark
New Delhi: With the administration of more than 56 lakh vaccine doses in the last 24 hours, India’s Covid-19 vaccination coverage on Saturday exceeded 165.04 crores, as per the health ministry report.…
- India
India to begin administering ‘precaution dose’ of COVID vaccine on Monday
New Delhi: The administration of ‘precaution dose’ of COVID-19 vaccine to healthcare, frontline workers and those above 60 years in the country is set to begin on Monday. The online registration for…
- India
SII applies to Indian authorities for full market authorisation of Covishield
New Delhi: Serum Institute of India (SII) CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies of the COVID-19…
- World
Lab worker tests positive after being bitten by mouse with Covid
Health officials in Taiwan are investigating whether a mouse bite is responsible for a laboratory worker falling sick and if it can possibly lead to a new COVID-19 outbreak on the island. …
- Health
Omicron: What are experts saying about its symptoms, treatment, vaccine efficacy
Coronavirus has killed 5.2 million people worldwide and infected 257 million people in total. With the images of the recent second wave still sending chills down our spines, the upcoming third wave…
- India
Rahul raises concern, says new Covid variant is a serious threat
New Delhi: Former Congress chief Rahul Gandhi on Saturday expressed concern over the emergence of a new coronavirus variant and asked the government to provide vaccine security to the people of the…
- Offbeat
Drunkards don’t lie: MP official’s bizarre comment triggers meme fest on Twitter
“Those who drink don’t lie,” said no saint ever but the excise officer of Madhya Pradesh’s Khandwa district made this rather bizarre statement while explaining the process of the sale of liquor…
- Health
Covaxin found to be 77.8% effective against COVID-19: Lancet
Hyderabad: Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech’s Covaxin. As per phase-three clinical trials data, Covaxin demonstrates 77.8 per cent efficacy against…
